Market Value: Alpha Cognition Inc (ACOG)
Alpha Cognition (ACOG) focuses on developing oral medications for dementia and other brain impairments, mitigating risks through an extensive portfolio of tests. This price action for the company on GURU.Markets is 0.19. Revenue is based on the sale of cognitive treatments via government programs and insurance. Sales stability is ensured by proven distribution channels and strategic raw material stockpiling.
ACOG (alphacognition.com): analytical breakdowns and indicator data
- current price and projected stock value:
- company stock exchange capitalization indicators:
- book value of equity indicators:
- debt and liquidity data:
Total Debt to Capital Alpha Cognition|ACOG - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Alpha Cognition Inc.|ACOG - Company Aggregate Debts|Debt to Book Capitalization Ratio Alpha Cognition Inc.|ACOG - Company Long-Term Loans and Borrowings|Company Short-Term Debt Alpha Cognition|Quick Ratio alphacognition.com
- financial results and valuation multiples details:
ACOG - Net Profit|Expected Profit Alpha Cognition|ACOG - Price to Earnings Ratio|Future Price to Earnings Alpha Cognition Inc.|ACOG - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Alpha Cognition Inc.|ACOG - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Alpha Cognition|ACOG - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months alphacognition.com|ACOG - Earnings per share increase in current year|Earnings growth forecast for next year Alpha Cognition
Fundamental company analysis:ACOG (Alpha Cognition Corp)
The scale of Alpha Cognition (ACOG) is defined by the uniqueness of its developments in Alzheimer's disease therapy. Market capitalization, calculated as the share price multiplied by the total number of shares, measures the aggregate value of the business in the eyes of the market. Investors evaluate this indicator to weigh speculative noise against the real value of patent barriers and FDA approval. The stability of the company's total equity value confirms the fundamental strength of its assets. This chart's dynamics allow for the timely recognition of a shift in valuation trends.
Key competitors
Market Capitalization BIIB (Biogen)|NBIX - Market Valuation|RGC - Market Value|Market Value Axsome Corp|ACAD: Market Capitalization|Market Capitalization xenon-pharma.com XENE|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Market Value|Market Value Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Market Capitalization|Market Capitalization Prothena Corp|Market Value Alector, Inc. (ALEC)|Market Value ANNX (Annexon Biosciences)|Market Value Omeros OMER|NGNE (Neurogene Therapeutics) - Market Valuation|AC Immune - Market Capitalization|Market Value VYGR (voyagertherapeutics.com)|NMRA: Market Capitalization|Scilex Holding (SCLX) - Market Capitalization|Market Valuation TVGN|CGTX: Market Value|Market Capitalization IKT|Market Valuation cassavasciences.com SAVA|Market Value Assertio ASRT|Coya Therapeutics Inc (COYA) - Market Value|VistaGen Therapeutics Inc - Market Capitalization|Market Capitalization Ovid Therapeutics Inc. (OVID)|Acumen Pharmaceuticals (ABOS) - Market Value|Market Capitalization CRVO|ATHE (Alterity Therapeutics Ltd.) - Market Capitalization|Clene Nanomedicine (CLNN) - Market Capitalization|Market Valuation PEPG (PepGen Inc.)|Market Value JUNS|Market Capitalization RLMD (Relmada Therapeutics)|Market Capitalization annovisbio.com (ANVS)|GRCE - Market Value|Market Value Firefly Neuroscience, Inc.|anewmeds.com (KLTO) - Market Value|Market Capitalization NRSN|RVPH (Reviva Pharmaceuticals) - Market Capitalization|Market Capitalization MetaVia, Inc.|Market Capitalization NRXS|Market Valuation heliusmedical.com HSDT|Market Value Passage Bio PASG|Neuphoria Therapeutics, Inc. (NEUP) - Market Value|Minerva Neurosciences - Market Capitalization|Market Capitalization athira.com (ATHA)|Addex Therapeutics Ltd (ADXN) - Market Value|Market Capitalization ALZN|CYCN (Cyclerion Therapeutics Inc.) - Market Capitalization|Market Value Protagenic PTIX|Market Valuation KTTA (Pasithea Therapeutics)|Market Capitalization cortigent.com (CRGT)|Market Value Avenue Therapeutics, Inc. ATXI|Market Value BCLI|CARA - Market Value|Market Value Chromocell|ELYM: Market Capitalization|Intra-Cellular Therapies, Inc. (ITCI) - Market Capitalization|Market Value Longboard Pharmaceuticals, Inc.|Market Value MRNS|Market Value NKGen (NKGN)|NRBO: Market Valuation|Market Capitalization SAGE (Sage Therapeutics, Inc.)|Market Value SNPX|Trevena - Market Capitalization|VIGL - Market Capitalization|WENA (Anew Medical, Inc.) - Market Valuation|Cerevel Corp - Market Value
